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to DNAase 1 or to T3 RNA polymerase in pre-B cellsand Department of Biology
from transgenic mice carrying an integrated enhancer.Brandeis University
The intensity of the DNAase 1 hypersensitive site andWaltham, Massachusetts 02454
distal accessibility was accentuated by the presence
of matrix attachment regions in the same constructs
(Forrester et al., 1994; Jenuwein et al., 1997). RecentSummary
analysis of targeted deletions of the core m enhancer
and/or the adjacent matrix attachment regions clearlyDirected accessibility mediated by antigen-receptor
demonstrates that the core enhancer is necessary togene enhancers ensures developmental stage±specific
direct normal V(D)J recombination during B cell develop-activation of V(D)J recombination. Here, we used a
ment (Sakai et al., 1999). Taken together with earliercombination of in vitro and in vivo assays to explore the
studies on recombination substrates, these data con-mechanisms that regulate immunoglobulin m heavy
vincingly demonstrate that the m enhancer regulateschain gene enhancer±dependent chromatin accessi-
chromatin accessibility.bility. Ets-1 or PU.1 bound to m enhancer±containing
Regulating accessibility is a characteristic of all knownplasmids assembled into chromatin in vitro and in-
antigen receptor gene enhancers. The immunoglobulincreased restriction enzyme access to a proximal site.
k and l light chain gene enhancers have been tested inIn complementary analyses, expression of PU.1 in Ets-
recombination substrates and found to activate recom-1-containing 2017 pro-T cells or NIH 3T3 cells induced
bination (Kallenbach et al., 1993; Demengeot et al., 1995;sterile Im transcripts at the IgH locus and increased
Hiramatsu et al., 1995; Ferrandini et al., 1996). Similarly,accessibility of the endogenous m enhancer to restric-
the T cell receptor a, b, and d gene enhancers have beention endonucleases. These observations suggest that
used to activate recombination in transgenic substratesone role of PU.1 is to increase accessibility of the m
(Capone et al., 1993, 1995; Lauzurica and Krangel, 1994;locus to initiate heavy chain gene expression.
Roberts et al., 1997; Clevers and Ferrier, 1998). In these
assays, the enhancers closely reproduced the develop-
Introduction mental characteristics of the loci from which they were
derived. For example, recombination directed by the
The immunoglobulin m heavy chain gene intronic en- TCRb enhancer preceded that directed by the TCRa
hancer (m enhancer), located in the JH-Cm intron, is a enhancer, and the TCRd enhancer was activated close
regulatory region implicated in B cell development. Orig- to the stage when d gene rearrangements are normally
inally identified as a transcriptional activator, this en- observed. Furthermore, genetic deletion of TCRa and
hancer is now believed to play a critical role in V(D)J TCRb enhancers has been shown to adversely affect
recombination of the IgH locus. Three lines of evidence recombination (Bories et al., 1996; Bouvier et al., 1996;
support this idea. First, the m enhancer is sufficient to Sleckman et al., 1997). Despite the experimentally con-
activate recombination in artificial substrates at the ap- firmed role of enhancers in regulating locus accessibil-
propriate stage of B cell development (Oltz et al., 1993; ity, little is known about the mechanisms by which they
Fernex et al., 1994). Second, genetic deletion of the m alter chromatin structure.
enhancer adversely affects IgH rearrangement (Chen et The best studied example is the TCRa enhancer,
al., 1993; Serwe and Sablitzky, 1993). Interestingly, the whose core domain contains binding sites for CREB,
effect of deleting this enhancer is seen more strongly LEF-1/TCF, Ets-1, and CBF (Giese et al., 1995). Jones
at the stage of V to DJ recombination, whereas D to J and colleagues (Mayall et al., 1997) showed that each
recombination is affected minimally (Serwe and Sablit- of these factors will increase transcriptional activity of
zky, 1993; Sakai et al., 1999). Finally, deletion of the a chromatin assembled template in vitro; when two or
enhancer has recently been shown to decrease class more factors were present, transcription levels in-
switching at the m locus (Bottaro et al., 1998). These creased commensurately. Addition of factors individu-
observations show that the m enhancer increases acces- ally or in combination generated a DNAase 1 hypersensi-
sibility of the IgH locus to the recombinase machinery. tive site whose intensity was not significantly affected
Control of locus accessibility by the m enhancer was by the number of proteins present. A different perspec-
first suggested by identification of a B cell±specific tive on accessibility was provided by the recent studies
of Hernandez-Munain et al. (1998). They used in vivoDNAase 1 hypersensitive site coincident with enhancer
footprinting to demonstrate that all TCRa enhancersequences (Mills et al., 1983). m enhancer±dependent
binding sites within the minimal enhancer were occupiedaccessibility was later addressed in greater detail in
in vivo and mutation of any one of the sites resulted in
loss of footprints over all the elements. The in vitro stud-* To whom correspondence should be addressed (e-mail: sen@
ies suggest that any of the TCRa enhancer binding pro-binah.cc.brandeis.edu).
teins bind chromatin templates and enhance accessibil-² Present Address: Boston University Medical Center, Departments
of Medicine and Microbiology, Boston, Massachusetts 02118. ity, whereas the in vivo studies indicate that the full
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Figure 1. In Vitro Chromatin Assembly on m
Enhancer-Containing Plasmids
(A) Schematic representation of m enhancer
plasmid used in in vitro chromatin assembly.
Motifs of the m enhancer are indicated by
squares and ovals. The ETS protein binding
sites, mA and mB, bind Ets-1 and PU.1, re-
spectively. The bHLH protein E47 binds to
mE2 and mE5 elements, and bHLH-zip pro-
teins such as TFE3 and USF bind to the mE3
site. The five-component enhancer shown
activates B cell±specific transcription as a
monomer.
(B) Time course of nucleosome assembly in
Xenopus egg extracts. Plasmid DNA was in-
cubated with Xenopus egg extracts. After the
indicated amounts of time, DNA was purified
and assayed by agarose gel electrophoresis.
An ethidium bromide stained gel is shown.
(C) Bulk micrococcal nuclease digestion pat-
terns of chromatin assembled in the absence
(lanes 1±5) and presence (lanes 6±10) of PU.1.
MNase digestion was carried out for 1, 3, 7,
or 30 min (lanes 2±5 or 7±10), followed by
purification of DNA and fractionation by aga-
rose gels. DNA was transferred to nitrocellu-
lose filters that were hybridized to a radioac-
tive probe containing m enhancer sequences.
Letters a±e mark mono-, di-, tri-, tetra-, and
penta-nucleosome fragments, respectively.
complement of proteins is required to get protein occu- gene enhancers. To elucidate the role of ETS proteins
in regulating m enhancer±dependent chromatin accessi-pancy on the enhancer.
Accessibility of the m locus to DNA-binding proteins bility, we used a combination of in vitro and in vivo
assays. We show that both Ets-1 and PU.1 bind to mhas been questioned since the original in vivo footprint
analysis (Ephrussi et al., 1985). These investigators ob- enhancer-containing plasmids assembled into chroma-
tin in vitro. Binding did not alter the bulk nucleosomalserved proteins bound to the m enhancer DNA only in B
cells, leading them to conclude that enhancer activation array over the enhancer but increased accessibility of
enhancer DNA to restriction endonucleases. To deter-was mediated by B cell±specific transcription factors.
However, when candidate DNA-binding proteins were mine the validity of these observations, we examined
sterile transcription and chromatin structure of the en-identified, the DNA elements defined by Ephrussi et al.
were shown to bind ubiquitously expressed proteins. dogenous IgH locus. Im transcripts were not evident in
cell lines that contained only PU.1 or Ets-1; however,Because ubiquitous proteins were expressed but did
not bind m enhancer sites in non-B cells, it was proposed transient PU.1 expression in Ets-1-containing 2017 (pro-T)
cells and NIH 3T3 cells induced Im transcripts. Finally,that cell-specfic m enhancer binding proteins allow ubiq-
uitously expressed proteins access to DNA elements retrovirus-mediated PU.1 expression in 2017 and NIH
3T3 cells induced sterile Im transcripts and altered theonly in B cells (Sen and Baltimore, 1986). Additional
elements in the m enhancer that bind proteins with structure of the endogenous locus as assessed by endo-
nuclease accessibility. These observations suggest thatlimited tissue distribution were described subsequently
(Libermann and Baltimore, 1990; Nelsen et al., 1990, PU.1 modulates the structure of the IgH locus to initiate
recombination and gene expression.1993).
Transcriptional activity of the m enhancer is controlled
by ubiquitously expressed proteins, such as the basic Results
helix-loop-helix (bHLH) proteins E47 and TFE3 and more
tissue-restricted ETS proteins such as Ets-1 and PU.1. ETS Protein Binding to In Vitro
Assembled ChromatinAmong these, the ETS family members have been pro-
posed to determine the tissue specificity of the enhancer To study the role of ETS proteins in determining B cell±
specific m enhancer activity, we assembled a plasmid(Nelsen et al., 1993), and coexpression of PU.1 and Ets-1
is sufficient to activate a minimal m enhancer in non- containing a 76 bp fragment of the m enhancer (bp 359±
435; see Figure 1A) (Ephrussi et al., 1985) into chromatinlymphoid cells. We have also provided evidence that
the ubiquitously expressed proteins interact with ETS using an in vitro chromatin assembly system from Xeno-
pus laevis eggs as previously detailed (Laskey and Earn-members to boost the levels of tissue-specific gene
expression (Nikolajczyk et al., 1997; Dang et al., 1998). shaw, 1980; Sanchez et al., 1995). A monomer of this
fragment enhances transcription from a minimal pro-ETS family proteins have also been implicated in the
function of the TCRa, b, and k39 enhancers, suggesting moter only in B cells, and all five known protein binding
sites within this fragment are required for high levelsthat they are important regulators of antigen receptor
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of transcriptional activation (Dang et al., 1998). In vitro
chromatin assembly was monitored by the supercoiling
assay. At early time points, agarose gel electrophoresis
showed that the highly supercoiled input plasmid (Figure
1B, 09) was first relaxed by topoisomerase activity in the
Xenopus egg extract (159-309). With extended incuba-
tion, the plasmid was resupercoiled due to the deposi-
tion of nucleosomes. Assembly was complete in 150
min. Similar samples analyzed on chloroquine-con-
taining agarose gels, which more clearly separate differ-
entially supercoiled plasmid species (Shen and Hu,
1986), confirmed that nucleosome assembly was essen-
tially complete (data not shown). Note that the extent
of supercoiling induced by extract was similar to that
of the input plasmid.
We further tested whether nucleosomes were assem-
bled into regularly spaced arrays on the m enhancer±
containing plasmid by micrococcal nuclease (MNase)
digestion followed by Southern analysis with a m76-
specific probe (Figure 1C). MNase cleaves chromatin
assembled DNA preferentially in the internucleosomal
linker DNA, and the specific probe detects chromatin
structure in the immediate vicinity of the m enhancer.
The MNase digestion of chromatin assembled for 150
min revealed DNA fragments whose lengths were multi-
ples of 170 bp (labeled a±e). Unassembled plasmids
digested for 1 min, the shortest time point measured,
yielded fragments of all sizes as demonstrated by
smears on agarose gels, confirming that the enhancer
DNA was assembled into nucleosomal arrays by the Figure 2. PU.1 and Ets-1 Bind Nucleosome Assembled DNA
Xenopus extracts (data not shown).
Unassembled DNA (lane 1) or DNA assembled into chromatin in
Three sequence motifs present in this enhancer frag- vitro in the absence of added proteins (lane 2) or in the presence
ment, mE2, mE3, and mE5, bind widely expressed pro- of ETS domain of Ets-1 [ETS(Ets-1), lane 3], full-length PU.1 (lane
teins such as E47, TFE3, and USF. However, binding of 4), or ETS(Ets-1) plus PU.1 (lane 5) was treated with DNAase1. After
purification of the DNA, the DNAase1-induced nicks were detectedthese factors to the m enhancer is absent in non-B cells
by primer extension with a radioactive oligonucleotide that hybrid-(Ephrussi et al., 1985), leading to the proposal that more
izes to the lower strand of the m enhancer DNA. Open arrows markcell-restricted factors may alter the accessibility of m
the positions of bands that are missing in the PU.1-containing as-
enhancer DNA in vivo (Sen and Baltimore, 1986). ETS sembly, open circles mark the position of bands that are missing
proteins, which also bind linear m enhancer, are ex- in ETS(Ets-1)-containing reactions, and closed circles represent hy-
pressed in a cell-restricted pattern (Nelsen et al., 1993; persensitive cleavage sites in the presence of ETS(Ets-1). Positions
of the mA, mE3, and mB sites are indicated. Note that several bandsNikolajczyk et al., 1997). We therefore tested whether
in lane 3 are not marked as hypersensitive because of the increasedETS proteins could bind their sites, mA and mB, in the
overall counts in this lane.context of in vitro assembled chromatin, and if so
whether the binding affected chromatin structure. We
assembled chromatin in the presence of Ets-1 and/or
demonstrate that PU.1 binds m enhancer DNA in thePU.1 and then analyzed the resulting complex by limited
context of chromatin.DNAase 1 digestion (Pazin et al., 1996). Because chro-
For parallel experiments with Ets-1, we used a trun-matin reconstitution was carried out with a closed circu-
cated form of the protein that lacks the N-terminallar plasmid, the DNAase 1 digestion pattern was visual-
autoinhibitory domain (ETS [Ets-1]) (Nikolajczyk et al.,ized by primer extension using a radiolabeled primer.
1996) and hence binds the mA site with higher affinityThe DNA banding pattern resulting from limited DNAase
(Jonsen et al., 1996). Assembly in the presence of ETS1 digestion of the plasmid was dependent on assembly
(Ets-1) altered the DNAase 1 digestion pattern over thestatus of the plasmid (Figure 2, compare lanes 1 and 2).
mA site, as evidenced by multiple protected and hyper-PU.1 bound the mB site in the nucleosome assembled
sensitive bands (Figure 2, lane 3, open and closed cir-plasmid, as evidenced by multiple protected bands (Fig-
cles, respectively). The extended ETS(Ets-1) footprinture 2, lane 4, open arrows). Weaker binding of PU.1 to
over mA is reminiscent of the Ets-1 footprint pattern onthe mA site was evidenced by incomplete protection
naked m enhancer DNA (Rao et al., 1997). ETS (Ets-1)of several DNAase 1 sensitive bands within mA (open
did not bind to a plasmid that contained a mutated mAarrows). Strong binding of PU.1 to mB and weaker bind-
sequence (data not shown). When PU.1 and ETS(Ets-1)ing to mA in this analysis was consistent with PU.1 bind-
were added simultaneously to an assembly reaction,ing activity on linear naked DNA (Rao et al., 1997). PU.1
these proteins bound the mB and mA sites, (Figure 2,binding was undetectable on an assembled mB2 mu-
lane 5). Because the banding pattern over the mB ele-tated m enhancer plasmid as evidenced by the lack of
DNAase1 protections (data not shown). These results ment more closely resembled the mB/PU.1 pattern
Immunity
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Figure 3. PU.1 and Ets-1 Increase Accessi-
bility of Chromatin to Restriction Endonu-
clease
(A) Schematic representation of the accessi-
bility assay protocol.
In vitro assembled chromatin (large circle
represents plasmid, small ovals represent
nucleosomes) was digested with XbaI under
limiting conditions, followed by deproteina-
tion and purification of DNA. Purified DNA
was cut to completion with BglII and then
fractionated by electrophoresis through aga-
rose gels. DNAs were transferred to nylon fil-
ters that were hybridized to a radioactive
probe. The XbaI and BglII digestion releases
a 121 bp fragment.
(B) XbaI restriction endonuclease accessibil-
ity to chromatin assembled on wild-type plas-
mid in the presence of increasing amounts of
buffer (lanes 1 and 2), PU.1 (lanes 3 and 4),
or Ets-1 (lanes 5 and 6). Lanes 8 and 9 show
the XbaI accessibility assay on chromatin as-
sembled on a mB mutated or mA mutated
plasmid in the presence of PU.1 or Ets-1, re-
spectively. The XbaI±BglII fragment, a mea-
sure of DNA accessibility to the XbaI enzyme,
is indicated by an arrow.
(C) Quantitation of accessibility blot shown in
(B). Lane numbers in (C) correspond directly
to lane numbers in (B). A phosphorimager was
used to quantitate the radioactivity present
in the XbaI±BglII fragment and the linear plasmid. Data are shown as the ratio of counts present in the fragment to counts present in the
linear plasmid. (B) and (C) show the results from one representative experiment of four independent assays.
(vertical line), and the banding pattern over the mA site bound ETS proteins changed the accessibility of restric-
tion endonucleases to chromatin assembled m enhancermore closely resembled the extended mA/ETS(Ets-1)
pattern, we hypothesize that in the context of chromatin, DNA. Increased restriction enzyme accessibility of en-
dogenous genes correlates with structural changes inPU.1 preferentially binds mB and Ets-1 binds mA, consis-
tent with the known higher affinity of PU.1 for mB and cellular chromatin, as exemplified by studies with the
erythroid-specific b globin gene enhancer (Boyes andEts-1 for mA (Rao et al., 1997). Parallel experiments ex-
amining the ability of the mE3 binding protein TFE3 to Felsenfeld, 1996). The experimental design is outlined
in Figure 3A and uses an XbaI endonuclease site thatbind to nucleosome assembled m enhancer failed to
demonstrate TFE3 binding to chromatin (data not shown). lies 46 and 76 bp from the mA and mB sites, respectively.
Assembly of the m enhancer±containing plasmid intoTo determine whether PU.1 binding altered the nucleo-
somal array, we assembled chromatin in the presence chromatin essentially abolished DNA cutting by XbaI
(compare Figure 3B, lanes 1 and 2). In the presence ofof PU.1 and assayed chromatin structure by MNase
digestion. MNase-treated DNA was fractionated by aga- either PU.1 or Ets-1, the extent of XbaI cutting was
enhanced (Figure 3B, lanes 3±6) compared to chromatinrose gel electrophoresis and transferred to nitrocellu-
lose membranes that were probed with a m enhancer assembled in the presence of protein dilution buffer
probe (Figure 1C). PU.1 had no effect on the MNase alone (lanes 1 and 2). Additionally, PU.1 and Ets-1 ex-
digestion of plasmid lacking the m enhancer (data not erted their effects on accessibility through binding the
shown). Furthermore, despite subtle differences in mB and mA sites, respectively, because mutation of
MNase patterns from plasmids assembled in the ab- these sites abrogated ETS-mediated increased accessi-
sence (lanes 1±5) and presence (lanes 6±10) of PU.1, bility (lanes 8 and 9). Phosphorimager quantitation of
these data indicate that PU.1 binding did not signifi- Figure 3B (Figure 3C) demonstrated that the maximum
cantly disrupt the nucleosomal array over the m en- amounts of PU.1 and Ets-1 tested (Figure 3B, lanes 4
hancer. We probed the same blot with a plasmid-spe- and 6) increased DNA accessibility to approximately the
cific probe located 1.0 kb away from the PU.1 binding same extent. The DNA binding ETS domain of Ets-1
site. Distal regions of the plasmid did not show signifi- increased XbaI accessibility to the same extent as full-
cant alterations in the nucleosomal pattern (data not length Ets-1 (data not shown).
shown). We conclude that PU.1 binds to m enhancer± We further confirmed that PU.1 and Ets-1 binding did
containing plasmids assembled into chromatin, without not affect cleavage at the XbaI site in naked DNA (data
grossly affecting DNA structure. not shown). Plasmid DNA was incubated with the ETS
protein as indicated, followed by addition of Xenopus
egg extracts and XbaI at the same time. This ensuredRestriction Endonuclease Accessibility
to the m Enhancer that total protein content was the same under experi-
mental or control conditions but precluded chromatinTo probe whether ETS family members altered chroma-
tin structure in a more subtle way, we tested whether assembly. As expected, access of XbaI to its recognition
ETS Proteins in Chromatin Accessibility
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sequence was much higher in unassembled plasmid,
and accessibility remained constant whether or not ETS
proteins were present in the binding reaction (data not
shown). The unassembled DNA control was particularly
important for PU.1, a protein that is known to bend
DNA (Nikolajczyk et al., 1996) and generate a DNAase1
hypersensitive site on naked DNA (Rao et al., 1997).
Overall, these experiments indicate that the ETS domain
proteins can enhance restriction enzyme accessibility
to chromatin assembled m enhancer DNA.
PU.1 Activates Sterile Im Transcripts In Vivo
To investigate the physiological significance of these
in vitro observations, we tested whether ETS proteins
altered cellular chromatin accessibility by measuring
sterile m transcriptional activity of an unrearranged IgH
locus. It is generally believed that sterile transcripts re-
sult from changes in DNA accessibility to RNA polymer-
ase and are a necessary prelude to V(D)J recombination
(Sleckman et al., 1996). The earliest committed B lineage
precursor, the A0 cell, produces sterile transcripts initiat-
ing within the m enhancer but lacks RAG expression
(Li et al., 1996), indicating that the m locus is accessible
to the transcriptional machinery before DH to JH re-
arrangement. Two sterile transcripts have been charac-
terized in the unrearranged IgH locus; Im transcripts
initiate 39 of the m enhancer within the JH-Cm intron and
mO transcripts start upstream of the JH gene segments.
Both transcripts can be detected by reverse tran-
scriptase PCR. Differences in sterile transcription were
the basis of subsequent studies on two pro-T cell lines,
2052C and 2017, which represent early stages of T cell
differentiation because the T cell receptor genes are
in an unrearranged configuration (Spolski et al., 1988). Figure 4. Induction of Sterile Im Transcripts in 2017 Pro-T Cells
2052C cells, the less differentiated of the two lines, ex- (A) Sterile transcripts in untransfected cell lines. Total RNA from
indicated cells was analyzed by reverse transcription followed bypress both PU.1 and Ets-1 (Nelsen et al., 1993; data not
PCR for Im expression as described by Schlissel et al. (1991b). 2052Cshown). 2017 cells lack PU.1 but express high levels of
and 2017 are pro-T cell lines. 2052C express PU.1 and Ets-1, 2017Ets-1 (see below). Sterile Im as well as mO transcripts
cells express Ets-1 but not PU.1; mouse erythroleukemia cells (MEL)were detected by RT-PCR analysis in 2052C cells but
express PU.1, and RAW 264-7 macrophage cells express PU.1.
not in 2017 cells (Figure 4A, lanes 1 and 2, respectively; HAFTL, pro-B cells were used as a positive control. Lane 6 is a
data not shown). The pro-B line HAFTL, a line that under- negative PCR control lacking cDNA.
goes DH to JH recombination in culture and expresses (B±E) PU.1, Im, Ets-1, and GAPDH expression in transfected 2017
cells detected by RT-PCR. EVRF, PU.1, or Ets-1 above the lanesboth PU.1 and Ets-1, was a positive control for Im tran-
indicates transfected empty vector, PU.1, or Ets-1 expression vec-scription (Figure 4A, lane 5). However, sterile IgH tran-
tor, respectively. PU.1, Ets-1, and GAPDH signals were detected byscripts were not evident in the macrophage cell line
ethidium bromide staining; for Im detection, the PCR products wereRAW264.7 or in mouse erythroleukemia (MEL) cells (Fig-
transferred to nylon filters that were hybridized to a Cm-specific
ure 4A, lanes 3 and 4, respectively) that express high probe. Results shown are from one of four independent transfection
levels of endogenous PU.1. Interestingly, in vivo foot- experiments.
print analysis had previously shown that protein binding
sites in the m enhancer are unoccupied in MEL cells
showed that PU.1 expression but not Ets-1 expression(Ephrussi et al., 1985). These observations are consis-
induced Im transcripts (Figure 4C, compare lanes 2 andtent with PU.1 being necessary but not sufficient to
3 with lane 4). Consistent with earlier studies (Schlisselestablish RNA polymerase access to the IgH locus.
et al., 1991a), the basic helix-loop-helix protein E47 alsoTo investigate whether ETS proteins increased RNA
induced Im transcripts in our transient assays (data notpolymerase II access in vivo, we expressed high levels of
shown). As a control, we confirmed that GAPDH expres-PU.1, or Ets-1, in 2017 cells by lipofectamine-mediated
sion was comparable in all the RNA samples (Figure 4E).transient transfection. PU.1 expression in transfected
The ability of PU.1 to induce sterile transcription incells was evident by RT-PCR analysis of two indepen-
an Ets-1-expressing early T cell line led us to questiondent samples (Figure 4B, lanes 2 and 3) and by EMSA
whether a PU.1/Ets-1 combination could activate the manalysis using a high-affinity PU.1 binding site (data not
locus in a developmentally distant cell type. Becauseshown). Although 2017 cells constitutively express Ets-1
all PU.1-expressing cells are in the hematopoietic lin-(Figure 4D, lanes 1±3), higher Ets-1 expression was evi-
eage, we focused on nonhematopoietic, Ets-1-express-dent in cells transfected with an Ets-1 expression vec-
tor (Figure 4D, lane 4). Analysis of sterile m transcripts ing NIH 3T3 cells (Nikolajczyk et al., 1997). We transiently
Immunity
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Figure 6. Stable PU.1 Expression in 2017 Cells and NIH 3T3 Cells
Induces Im TranscriptsFigure 5. Im Transcripts in NIH 3T3 Cells
(A) Sterile Im transcripts were assayed by RT-PCR from 2017 cellsNIH 3T3 cells were transiently transfected with an empty expression
and NIH 3T3 cells that express PU.1 as indicated above the lanes.vector (pEVRF) or a PU.1 expression vector. After 40 hr, total RNA
2017-PU.1 #1 and #2 are two clones of PU.1-expressing 2017 cells,was assayed for PU.1 expression (lanes 1 and 2), Im transcripts
and 3T3-PU.1 #1 and #3 are two clones of PU.1-expressing NIH 3T3(lanes 3 and 4), and GAPDH expression (lanes 5 and 6). Southern
cells. Negative controls include GFP-expressing 2017 cells and NIHblots were used to detect Im transcripts, whereas PU.1 and GAPDH
3T3 cells (lanes 1, 2, and 5). GAPDH expression (lower panel) wasexpression were evident by ethidium bromide staining. Results
used to confirm equal RNA in all reactions.shown are from one of two independent transfection experiments.
homogenous PU.1-GFP or control GFP-expressing pop-
transfected a PU.1 expression vector into NIH 3T3 cells, ulations. PU.1 expression was confirmed by RT-PCR
which resulted in high levels of PU.1 expression relative followed by Southern analysis with a probe specific for
to vector alone control (Figure 5, lanes 1 and 2). PU.1 the ETS domain of PU.1 (data not shown). Sterile Im
expression in NIH 3T3 cells activated Im sterile tran- transcripts were easily detected in PU.1-expressing
scripts (lanes 3 and 4), indicating that PU.1 facilitated 2017 and 3T3 cell cultures but not in the negative con-
formation of an active RNA polymerase II complex in a trols (Figure 6), thereby confirming earlier observations
nonlymphoid Ets-1-expressing cell line. GAPDH levels with transiently expressed PU.1.
were comparable between samples (lanes 5 and 6). Al- Chromatin structure of the IgH locus was assessed
though Ets-1 expression is a common feature of 2017 by restriction endonuclease accessibility. In brief, nuclei
and NIH 3T3 cells, we cannot rule out the possibility were treated with either PvuII or PstI, enzymes that cut
that other ETS proteins may also cooperate with PU.1 within the m enhancer (Figure 7A). Genomic DNA purified
to activate Im transcripts. from these cells was digested to completion with Bsu36i
and analyzed by Southern blotting. Enhanced cleavage,
indicative of increased accessibility of PvuII/PstI, wasPU.1 Alters Chromatin Structure In Vivo
Activation of sterile Im transcription is a measure of the visualized as a unique 856 bp Bsu36i±PvuII/PstI band
when probed as indicated (Figure 7A). Under the condi-accessibility of the IgH locus to RNA polymerase II. In
most studies, transcriptional accessibility has corre- tions of our assay, this restriction fragment was not
detectable in PU.1-negative 2017 cells treated with PvuIIlated well with the accessibility of antigen receptor loci
to the V(D)J recombinase machinery, which is presum- but was evident in the 2017-PU.1 clone 1 (Figure 7B,
compare lanes 1 and 2). Equal DNA loading in theseably dependent on the alteration of chromatin structure.
More recently, however, there have been several exam- lanes was evident from the full-length Bsu36i±Bsu36i
bands that include the fragment containing the enhancerples where the transcription/recombination correlation
has broken down. For example, Okada et al. (1994) ob- and the fragment located immediately 59 (because the
probe spans the 59 Bsu36i site shown; Figure 7B, lanesserved transcriptional activity but no recombination,
and, conversely, Angelin-Duclos and Calame (1998) ob- 1 and 2, lower panel). Enhanced cleavage by a second
restriction enzyme, PstI, was also observed in theseserved recombination but no transcription of germline
VH gene segments. To directly determine whether PU.1- cells compared to lines not expressing PU.1 (data not
shown). In addition, a second clone of PU.1-expressingdependent Im transcriptional activity was accompanied
by alterations in chromatin structure, we examined the 2017 cells behaved similarly, though the level of accessi-
bility was somewhat lower (data not shown).accessibility of the endogenous IgH locus to restriction
enzymes. Parallel analysis with NIH 3T3 cells demonstrated that
stable PU.1 expression increased m locus access toLow efficiency of transient transfection assays de-
scribed above precluded analysis of the structure of the PvuII in both cloned (Figure 6B, compare lanes 4±6 with
lane 3) and bulk (data not shown) populations. Increasedendogenous IgH locus. Therefore, mouse stem cell virus
containing either green fluorescent protein (GFP) alone access ranged from 1.8-fold (lane 6) to 2.4-fold (lane 4)
according to phosphorimager analysis. Intensity of theor GFP plus a full-length PU.1 cDNA were used to pro-
duce 2017 and NIH 3T3 cell derivatives in which a large 59 Bsu36i fragment was roughly equal in all samples
indicating that the amount of DNA loaded in each laneproportion of cells expressed PU.1. Infected cells were
purified by fluorescence-activated cell sorting to yield was comparable (Figure 7B, lanes 3±6, lower panel).
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Figure 7. Endonuclease Accessibility Assays
in 2017 and NIH 3T3 Cells
(A) Schematic representation of the IgH locus
showing the relevant restriction enzyme sites
used in these assays. The Bsu36i fragment
containing the m enhancer is labeled ªAº and
the upstream Bsu36i fragment detected by
the probe is labeled ªBº in the auto radio-
graph. Nuclei were treated with PvuII or PstI
followed by isolation of the genomic DNA.
Prior to Southern blot analysis, the genomic
DNA was cut to completion with Bsu36i and
the blots probed with the fragment indicated.
When PvuII or PstI cuts nuclear DNA, a
Bsu36i±PvuII (or PstI) fragment of approxi-
mately 0.8 kb should be detected. B, Bsu36i;
X, XbaI. The position of the core m enhancer
and the PvuII and PstI sites are indicated.
(B) Enhanced accessibility of PvuII in PU.1-
expressing clones of 2017 and NIH 3T3 cells.
Upper panel: 2017-PU.1 #1 clone (lane 2), un-
transfected 2017 cells (lane 1), 3T3-PU.1
clones #1, #2, or #3 (lanes 4±6), or 3T3-GFP
clone #1 (lane 3) were used to prepare nuclei
that were treated with PvuII and processed as
described above; arrow labeled ªm enhancerº
marks the position of the 0.8 kb Bsu36i±PvuII
fragment. Lower panel: full-length Bsu36i
fragments detected with the probe as loading
controls.
Similar analysis with PstI demonstrated that cutting at can increase accessibility of in vitro assembled chroma-
tin to restriction endonucleases. However, neither PU.1this site also increased 2- to 4-fold in PU.1-expressing
lines as compared to control GFP-expressing lines (data alone (such as in RAW or MEL cells) nor Ets-1 alone
(such as in 2017 or NIH 3T3 cells) was sufficient tonot shown). In summary, analyses on PU.1-expressing
2017 and NIH 3T3 cells demonstrate that stable PU.1 enhance RNA polymerase accessibility as judged by
sterile Im transcription. A closed structure of the IgHexpression increases chromatin accessibility at sites
within the endogenous m enhancer. locus in 2017 cells and NIH 3T3 cells was directly ob-
served by endonuclease accessibility assays. PU.1 ex-
pression in these cells activated Im transcripts, as wellDiscussion
as increased restriction enzyme access, providing evi-
dence that PU.1 is a modulator of chromatin structureAntigen receptor gene enhancers are believed to func-
tion by altering chromatin structure, which allows ac- at the IgH locus. We propose that one role of PU.1 during
B cell development is to increase accessibility of the mcess of multicomponent RNA polymerase or V(D)J re-
combinase machinery to the different loci. It is likely that locus to initiate heavy chain gene rearrangement and
expression.transcription activation requires, in addition to access,
interactions of the machinery with DNA-bound tran- An important feature of our studies is the comparison
between in vitro and in vivo effects. Our interpretationscription activation domains and associated coactiva-
tors. It remains unclear whether analogous interactions of the in vitro studies is that either ETS protein has the
potential to disrupt chromatin structure. However, thisof the V(D)J recombinase with enhancer-bound proteins
are required for gene rearrangements. However, chro- potential is realized only in the appropriate circum-
stances in vivo. The milieu of 2017 and NIH 3T3 cells ismatin accessibility is a prerequisite for both processes.
Toward understanding the mechanisms by which such that expression of PU.1 in these cells perturbs
the structure of the locus enough to be measured asthese enhancers alter chromatin structure, we show that
ETS proteins, Ets-1 and PU.1, which bind to the sites enhanced restriction enzyme accessibility. Indeed, 2017
cells contain several m enhancer binding proteins suchessential for transcriptional activity of the Ig m enhancer,
Immunity
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as Ets-1, E47, TFE3, and octamer binding proteins, yet lack of synergy when more than one enhancer binding
protein is present.they lack sterile Im transcripts or enhanced accessibility.
One possibility is that these enhancer binding proteins
Experimental Procedurescannot access the IgH locus in the absence of PU.1,
which overcomes chromatin constraints to allow func-
In Vitro Chromatin Assembly and Analysistional interactions. Our observations suggest that PU.1-
m enhancer±containing plasmid (20±220 ng) was assembled ac-
dependent chromatin remodeling is an essential feature cording to Sanchez et al. (1995) using Xenopus egg extracts acti-
of IgH locus accessibility. It is likely that the inability of vated with calcium ionophore for 20 min (Wangh et al., 1995). Su-
individual protein or subsets of enhancer binding pro- percoiling status was determined by separating 10 ng assembled
plasmid on 1% agarose gels with or without 40 mg/ml chloroquineteins to modulate chromatin structure ensures that locus
added. Micrococcal nuclease analysis on 100 ng assembled DNAopening occurs only in limited cell types. What consti-
required addition of Ca21 to 2 mm followed by 3 units MNase pertutes the ªappropriate environmentº in which PU.1 can
sample. The reaction was incubated at 22±258C for 1±30 min before
act is not addressed by these experiments and remains quenching and processing the products as described (Workman et
a future goal. al., 1990). Products were separated on a 1.5% agarose gel and then
In earlier studies, 5-fold overexpression of E47 in 2017 transferred to nylon membranes before probing with either proximal
(m53 bp 376±435 according to Ephrussi et al., 1985) or distal (bpcells also activated sterile Im transcription (Schlissel et
1328±1578 of pSP72 plasmid) probes as previously described (Niko-al., 1991a). Although the structure of the locus was not
lajczyk et al., 1996). Results from two probes were indistinguishable.directly examined in that study, our observations are
Assembled DNA (35±50 ng) was analyzed by DNAase I footprints
not inconsistent with those findings. It is possible that as described (Pazin and Kadonaga, 1998). Egg extract was present
high levels of E47 circumvented the normal mechanisms during DNAase I treatment of unassembled plasmid.
that preclude IgH expression in 2017 cells; our sugges- For XbaI endonuclease analysis, 20 ng assembled DNA (1.5±2 ml)
was diluted to 10 ml with 10 mM Tris, 10 mM MgCl2, 50 mM NaCl,tion in this paper is that the normal mechanisms may
and 1 mM DTT (pH 7.9) (Buffer 2). Samples were placed at 378C,involve PU.1. In addition, we found that E47 protein also
and 20 units XbaI was added for 10 min before the reaction wasenhanced restriction enzyme access in vitro (data not
stopped with 10 ml GuHCl and processed as described (Sanchez
shown), indicating that this protein can also affect chro- et al., 1995). Precipitated DNA was cut to completion with BglII and
matin structure. Taken together, we propose that several then separated on a 1% agarose gel and processed for Southern
proteins, such as PU.1, Ets-1, and E47, are coordinately analysis using the proximal probe described above. To analyze XbaI
access on unassembled DNA, recombinant protein was incubatedrequired to alter the structure of the endogenous locus.
with the m enhancer-containing DNA for 30 min at 22±258C beforeThe coordinate requirement may reflect that each pro-
addition of egg extract, buffer 2, and XbaI for 10 min. Brief incubationtein is present in limiting amounts in B cells, a balance
of egg extract with the plasmid avoided the potential complication
that may be essential for correct development. of partial chromatin assembly occurring during enzyme treatment.
Clearly, we have not fully recapitulated the state of Blots were quantitated by phosporimager analysis. For all in vitro
the endogenous locus in our in vitro assays. The most chromatin experiments, recombinant ETS proteins and Xenopus
egg extract were added to the plasmid concomitantly, and the ETSimportant difference is that individual proteins were suf-
protein and extract remained present during enzyme treatment. Re-ficient to create enhanced access in vitro, and combina-
combinant ETS proteins were made as previously described (Niko-tions of proteins tested did not increase the level of
lajczyk et al., 1996).
accessibility significantly. In contrast, several proteins
are required to generate enhanced accessibility in vivo. T Cell/NIH 3T3 Cell Transfections and Analysis
Similar results were obtained in the in vitro analysis of 2017 pro-T cells (107) were transfected using Lipofectamine Plus
(Gibco-BRL) according to the manufacturer's protocol, and cellsthe TCRa enhancer. Addition of one to four proteins
were harvested 24±26 hr posttransfection. Nuclear extracts weredid not significantly alter the strength of a DNAase 1
made according to Dignam et al. (1983). Total RNA was isolatedhypersensitive site in chromatin reconstituted in vitro
using UltraSpec RNA as directed (Biotex) and was reverse tran-
(Mayall et al., 1997); however, mutation of a single pro- scribed (Schlissel et al., 1991b) using random hexamer priming. Im
tein binding site eliminated DNAase 1 hypersensitivity and m0 sterile transcripts were PCR amplified using primers de-
of the TCRa enhancer in vivo (Hernandez-Munain et scribed by Schlissel et al. (1991a) and detected by Southern blot
analysis using a CH-specific probe. Other gene-specific cDNAs wereal., 1998). Given our meager ideas about chromosome
PCR amplified using primers as follows:dynamics mediated by enhancers, the disparity between
PU.1, 59-GGGCCCGGGCTTCTGCACGGGGAG-39 andin vitro and in vivo observations may be explained by
59-GGAATGTCCTCCCTGTGT-39;
the following model. Based on several examples where Ets-1, 59-GTCGATCTCAAGCCGACTCTCA-39 and
promoters or enhancers have been found to be either 59-TGAGGCGGTCACAACTATCGTA-39;
fully occupied or completely empty, it is likely that coop- GAPDH, 59-CCATCACCATCTTCCAGGAG-39 and
59-CCTGCTTCACCACCTTCTTG-39.erative binding of several proteins to endogenous regu-
PU.1, Ets-1, and GAPDH levels were determined by ethidium bro-latory sequences will prove to be a general phenome-
mide staining. NIH 3T3 transfections were done with a CaPO4 trans-non. However, in the in vitro systems, individual proteins
fection kit from 59-39, according to the manufacturer's directions.
bind readily to naked or chromatinized DNA, suggesting RNA analysis was identical to procedures described for T cells.
that the deficiency lies in the ªaberrantº binding of indi- 2052C RNA was kindly provided by Plavi Mittal.
vidual proteins or incomplete sets of proteins in vitro.
Production and Analysis of Stable PU.1-ExpressingAlternatively, it is possible that enhanced accessibility
Cell Linesof the endogenous enhancer is the synergistic result
The MSCV retrovirus (Hawley et al., 1994) containing green fluores-of weak accessibility induced by individual proteins. In
cent protein (GFP) with or without PU.1 (DeKoter et al., 1998) was
addition, neighboring sequences, such as MARS, may transfected into the viral packaging cell line BOSC 23 and used to
further accentuate the extent of accessibility. In this infect 2017 or NIH 3T3 cells 48 and 72 hr posttransfection (Pear et
al., 1993). GFP-positive cells were isolated on a FACSVantage cellmodel, the deficiency of the in vitro system lies in the
ETS Proteins in Chromatin Accessibility
19
sorter with a 488 nm argon laser excitation source and deposited cytokine-dependent proliferation and differentiation of granulocyte/
macrophage progenitors. EMBO J. 17, 4456±4468.by an automated cell deposition unit as either bulk (20,000 cells/
well) or cloned (10 cells/well) populations. Dead cells were excluded Demengeot, J., Oltz, E.M., and Alt, F.W. (1995). Promotion of V(D)J
based on propidium iodide staining, and high FSC signals were recombinational accessibility by the intronic Ek element: role of the
excluded to prevent the deposition of doublets. Both bulk and k B motif. Int. Immunol. 7, 1995±2003.
cloned populations yielded similar results in all subsequent assays. Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate
PU.1, Im, or GAPDH transcripts were detected by RT-PCR as de- transcription initiation by RNA polymerase II in a soluble extract
scribed for the transient transfectants, except that RT-PCR ampli- from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475±1489.
fied PU.1 was detected by Southern blots using an EcoRI±KpnI
Ephrussi, A., Church, G.M., Tonegawa, S., and Gilbert, W. (1985). Bfragment of PU.1 cDNA that includes the ETS domain.
lineage-specific interactions of an immunoglobulin enhancer withRestriction endonuclease accessibility of the transduced cell lines
cellular factors in vivo. Science 227, 134±140.was determined according to Boyes and Felsenfeld (1996) using
Fernex, C., Caillol, D., Capone, M., Krippl, B., and Ferrier, P. (1994).50±100 units of either PvuII or PstI to treat isolated nuclei. Both
Sequences affecting the V(D)J recombinational activity of the IgHenzymes cut within the m enhancer at a site 40±45 bp upstream of
intronic enhancer in a transgenic substrate. Nucleic Acids Res. 22,the PU.1-binding mB site. Isolated genomic DNA was then cut to
792±798.completion with Bsu36i before Southern analysis. The upstream m
Ferrandini, L., Gu, H., De Smet, A., Rajewsky, K., Reynaud, C.A.,enhancer fragment was detected on Southern blots using a HindIII±
and Weill, J.C. (1996). Rearrangement-enhancing element upstreamXbaI probe from the J11 gene segment. Quantitation was done by
of the mouse immunoglobulin k chain J cluster. Science 271, 1416±phosphorimager analysis in all figures except Figure 7B, which was
1420.quantitated from X-ray film by densitometry.
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